Purpose
Though the socioeconomic burden of cancer on patients is increasing in South Korea, there is little research regarding the type of cancer that incurs the highest costs. This study analyzed the socioeconomic burden on cancer patients from 2011 to 2015 according to sex and age.
Materials and Methods
A prevalence-based approach was applied utilizing claim data of the National Health Insurance Service in Korea to estimate the socioeconomic burden of cancer on patients. Patients who received treatment for cancer from 2011 to 2015 were the study subjects. The total socioeconomic burden of their disease and treatment was divided into direct and indirect costs.
Results
There was an increase of 50.7% for 5 years, from 821,525 to 1,237,739 cancer patients. The cancer costs for men and women increased $8,268.4 million to $9,469.7 million and $3,626.5 million to $4,475.6 million, respectively. Furthermore, the 50-59-year-old age group accounted for a large portion of the total disease cost. Liver, lung, stomach, and colorectal cancers created the heaviest economic burdens on patients.
Conclusion
Overall, this study indicates new policies for cancer prevention, early detection, and postcancer treatment management are necessary to help limit the costs associatedwith cancer, especially in the elderly, and provides a foundation for establishing cancer-related health care policies, particularly by defining those cancers with heavier disease burdens.
Citations
Citations to this article as recorded by
Socioeconomic Burden of Psychiatric Cancer Patients: A Narrative Review Gniewko Więckiewicz, Sophie Weber, Iga Florczyk, Piotr Gorczyca Cancers.2024; 16(6): 1108. CrossRef
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim Yonsei Medical Journal.2024; 65(7): 371. CrossRef
Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea Byungyoon Yun, Juyeon Oh, Heejoo Park, Jinsoo Chung, Juho Sim, Jongmin Lee, Yangwook Kim, Jin-Ha Yoon Gastric Cancer.2024; 27(6): 1159. CrossRef
Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh Md. Shahjalal, Padam Kanta Dahal, Md. Parvez Mosharaf, Mohammad Morshad Alam, Mohammad Delwer Hossain Hawlader, Rashidul Alam Mahumud Cancer Reports.2024;[Epub] CrossRef
High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Dukhee Nho Journal of Korean Medical Science.2024;[Epub] CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study SuYeon Kwon, Gowun Kim, Seungwoo Cha, Kyungdo Han, Nam-Jong Paik, Won-Seok Kim Supportive Care in Cancer.2023;[Epub] CrossRef
Economic burden of cancer attributable to modifiable risk factors in Japan Eiko Saito, Shiori Tanaka, Sarah Krull Abe, Mayo Hirayabashi, Junko Ishihara, Kota Katanoda, Yingsong Lin, Chisato Nagata, Norie Sawada, Ribeka Takachi, Atsushi Goto, Junko Tanaka, Kayo Ueda, Megumi Hori, Tomohiro Matsuda, Manami Inoue Global Health & Medicine.2023; 5(4): 238. CrossRef
Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database Hyeree Park, Yu Rim Kim, Yerin Pyun, Hyundeok Joo, Aesun Shin Journal of Preventive Medicine and Public Health.2023; 56(4): 312. CrossRef
The effects of hospice care on healthcare expenditure among cancer patients Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park BMC Health Services Research.2023;[Epub] CrossRef
Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea Min Soo Yang, Minae Park, Joung Hwan Back, Gyeong Hyeon Lee, Ji Hye Shin, Kyuwoong Kim, Hwa Jeong Seo, Young Ae Kim Cancer Research and Treatment.2022; 54(2): 352. CrossRef
Income Disparities in Cancer Screening: A Cross-Sectional Study of the Korean National Health and Nutrition Examination Survey, 2013–2019 Vasuki Rajaguru, Tae Hyun Kim, Jaeyong Shin, Sang Gyu Lee Frontiers in Public Health.2022;[Epub] CrossRef
The cost of oral cancer: A systematic review Rejane Faria Ribeiro-Rotta, Eduardo Antônio Rosa, Vanessa Milani, Nadielle Rodrigues Dias, Danielle Masterson, Everton Nunes da Silva, Ana Laura de Sene Amâncio Zara, Antoine Eskander PLOS ONE.2022; 17(4): e0266346. CrossRef
The effect of cancer on traditional, complementary and alternative medicine utilization in Korea: a fixed effect analysis using Korea Health Panel data Dongsu Kim, Soo-Hyun Sung, Seungwon Shin, Minjung Park BMC Complementary Medicine and Therapies.2022;[Epub] CrossRef
Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han Journal of Korean Medical Science.2022;[Epub] CrossRef
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective Meng-Di Cao, Cheng-Cheng Liu, Hong Wang, Lin Lei, Maomao Cao, Yuting Wang, He Li, Xin-Xin Yan, Yan-Jie Li, Xin Wang, Ji Peng, Chunfeng Qu, Eleonora Feletto, Ju-Fang Shi, Wanqing Chen Cost Effectiveness and Resource Allocation.2022;[Epub] CrossRef
Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman Journal of Drug Assessment.2022; 11(1): 12. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2022; 23(12): 1126. CrossRef
Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020 Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun Epidemiology and Health.2022; 44: e2022111. CrossRef
Mechanisms of resistance to chemotherapy in non-small cell lung cancer Hye-Young Min, Ho-Young Lee Archives of Pharmacal Research.2021; 44(2): 146. CrossRef
Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim Korean Journal of Clinical Pharmacy.2021; 31(2): 153. CrossRef
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim Cancers.2021; 13(18): 4567. CrossRef
Economic burden of alcohol-related cancers in the Republic of Korea Minji Han, Binh Thang Tran, Heeyoun Cho, Jin-Kyoung Oh Drug and Alcohol Dependence.2020; 217: 108295. CrossRef
Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect.
Results From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.
Citations
Citations to this article as recorded by
Cost of illness of breast cancer in low- and middle-income countries: a systematic review Siew Wei Yeong, Sit Wai Lee, Siew Chin Ong Health Economics Review.2024;[Epub] CrossRef
Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy Ji Won Lee, Hoonji Oh, Ji Young You, Eun-Shin Lee, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Jung Seok An, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park European Journal of Cancer.2023; 191: 112952. CrossRef
Economic burden of breast cancer: a case of Southern Iran Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari, Ramin Ravangard Cost Effectiveness and Resource Allocation.2023;[Epub] CrossRef
Economic burden of breast cancer in northern Serbia Marko Milovic, Tatjana Tamas, Veljko Crnobrnja, Milica Paut Kusturica Frontiers in Public Health.2023;[Epub] CrossRef
Measuring Trends in the Socioeconomic Burden of Disease in Korea, 2007-2015 Tae Eung Kim, Ru-Gyeom Lee, So-Youn Park, In-Hwan Oh Journal of Preventive Medicine and Public Health.2022; 55(1): 19. CrossRef
The direct cost incurred by patients and caregivers in diagnosing and managing prostate cancer in Ghana Ebenezer Wiafe, Kofi Boamah Mensah, Kwaku Addai Arhin Appiah, Frasia Oosthuizen, Varsha Bangalee BMC Health Services Research.2022;[Epub] CrossRef
Cost analysis of breast cancer: a comparison between private and public hospitals in Iran Abolhasan Afkar, Habib Jalilian, Abolghasem Pourreza, Habibeh Mir, Abdolhosein Emami Sigaroudi, Somayeh Heydari BMC Health Services Research.2021;[Epub] CrossRef
The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia Ahmed Alghamdi, Bander Balkhi, Shahad Alqahtani, Hamoud Almotairi Healthcare.2021; 9(7): 907. CrossRef
Direct Medical Costs for Stage-Specific Breast Cancer: A Retrospective Analysis Qais Alefan, Alaa Saadeh, Rami J Yaghan Breast Cancer Management.2020;[Epub] CrossRef
Socioeconomic Burden of Cancer in Korea from 2011 to 2015 Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park Cancer Research and Treatment.2020; 52(3): 896. CrossRef
Structural and Molecular Docking Analytical Studies of the Predicted Ligand Binding Sites of Cadherin-1 in Cancer Prognostics
Olalekan Olanrewaju Bakare, Adewale Oluwaseun Fadaka, Marshall Keyster, Ashley Pretorius Advances and Applications in Bioinformatics and Chemistry.2020; Volume 13: 1. CrossRef
Influencing Factors of Transportation Costs regarding Healthcare Service Utilization in Korea Su Yeon Jang, Jeong Yeon Seon, In-Hwan Oh Journal of Korean Medical Science.2020;[Epub] CrossRef
Measuring the Economic Burden of Disease and Injury in Korea, 2015 Ye-Rin Lee, Bogeum Cho, Min-Woo Jo, Minsu Ock, Donghoon Lee, Doungkyu Lee, Moon Jung Kim, In-Hwan Oh Journal of Korean Medical Science.2019;[Epub] CrossRef
Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea Sola Han, Bo-Hyoung Jang, Hae Sun Suh, Deok-Sang Hwang Complementary Therapies in Medicine.2019; 44: 210. CrossRef
Financial barriers related to breast cancer screening and treatment: A cross-sectional survey of women in Kenya Sujha Subramanian, Robai Gakunga, Madeleine Jones, Asaph Kinyanjui, Emily Ochieng’, Nancy Gikaara, Maluni, David Wata, Anne Korir, Zipporah Ali Journal of Cancer Policy.2019; 22: 100206. CrossRef
The economic burden of rotavirus infection in South Korea from 2009 to 2012 Kyung Suk Lee, Ye-Rin Lee, So-Youn Park, In-Hwan Oh, Donald R. Olson PLOS ONE.2018; 13(3): e0194120. CrossRef
Household Costs of Breast Cancer Morbidity: An Empirical Assessment from Pakistan Hafiz Zahid Mahmood, Imran Hameed Khaliq, Zafar Iqbal Bhatti, Kimberly J. Wilson, Khalid Masood Gondal, Summaira Malik, Shakila Zaman SSRN Electronic Journal .2018;[Epub] CrossRef
Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma Kiyong Na, Jung-Yun Lee, Ji-Youn Sung, Gun Min Kim, Ja Seung Koo, Hyun-Soo Kim Virchows Archiv.2018; 473(2): 165. CrossRef
Breast Cancer Detection Using Infrared Thermal Imaging and a Deep Learning Model Sebastien Jean Mambou, Petra Maresova, Ondrej Krejcar, Ali Selamat, Kamil Kuca Sensors.2018; 18(9): 2799. CrossRef
The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer Seul Lee, Yun Hwa Kim, Seung Chul Kim, Jong Kil Joo, Dong Suh Seo, Ki Hyung Kim, Kyu Sup Lee Obstetrics & Gynecology Science.2018; 61(5): 615. CrossRef
The human circadian clock from health to economics Bala S. C. Koritala, Selim Çakmaklı PsyCh Journal.2018; 7(4): 176. CrossRef
Economic Burden for Lung Cancer Survivors in Urban China Xin Zhang, Shuai Liu, Yang Liu, Jian Du, Wenqi Fu, Xiaowen Zhao, Weidong Huang, Xianming Zhao, Guoxiang Liu, Zhengzhong Mao, Teh-wei Hu International Journal of Environmental Research and Public Health.2017; 14(3): 308. CrossRef
Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea Jong-Myon Bae Journal of Preventive Medicine and Public Health.2017; 50(4): 217. CrossRef
Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014 Błażej Łyszczarz, Ewelina Nojszewska BMC Cancer.2017;[Epub] CrossRef
The Economic Burden of Otitis Media in Korea, 2012: A Nationally Representative Cross-Sectional Study Young-Eun Kim, Ye-Rin Lee, So-Youn Park, Kyung Suk Lee, In-Hwan Oh BioMed Research International.2016; 2016: 1. CrossRef
The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach Young-hoon Gong, Seok-Jun Yoon, Min-Woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dongwoo Kim Journal of Korean Medical Science.2016; 31(Suppl 2): S168. CrossRef